The American Association for Cancer Research (AACR) and Bayer HealthCare are pleased to announce a new partnership that will expand AACR's Basic Cancer Research Fellowship Program for 2015.
The AACR-Bayer HealthCare Basic Cancer Research Fellowships represent a joint effort to provide critical support to postdoctoral and clinical fellows conducting basic cancer research at the earliest stages of their careers. Two fellowships are being provided through this partnership.
"The AACR is excited to partner with Bayer to help young scientists develop their careers and to broaden our fundamental understanding of cancer through basic research," said Mitch Stoller, executive director of the AACR Foundation. "At the start of their careers, researchers are particularly vulnerable to the current funding crisis for biomedical research and the AACR is committed to supporting these young investigators whose discoveries will drive progress against the more than 200 diseases we call cancer."
The expansion of this program is significant, as it is one of the most highly competitive fellowships offered by AACR. Bayer's commitment to funding these additional fellowships will ensure that more talented young investigators have the necessary resources to explore their innovative research ideas.
"We are pleased to offer these two grants as part of our new partnership with the American Association for Cancer Research and support talented young investigators to explore their innovative approaches in basic cancer research and help increase understanding in tumor biology," said Karl Ziegelbauer, PhD, Head of Therapeutic Research Groups at Bayer HealthCare. "Our collaboration with the AACR underscores Bayer's continuous commitment to advancing research in the field of oncology."
The 2015 recipients of the AACR-Bayer HealthCare Basic Cancer Research Fellowships are Mario A. Shields, PhD, Cold Spring Harbor Laboratory in Cold Spring Harbor, New York, and Michelle P. Cicchini, PhD, the University of Pennsylvania in Philadelphia.
Each grant will provide $55,000 for one year, beginning July 1, 2015.
AACR and Bayer will continue their partnership in 2016, where two new fellowship opportunities will be available: the AACR-Bayer HealthCare Prostate Cancer Research Fellowship and the AACR-Bayer HealthCare Hepatocellular Carcinoma Research Fellowship.
The research proposed for funding may be basic, translational, clinical, or epidemiological in nature and must have direct applicability and relevance to either prostate cancer or hepatocellular carcinoma. These funding opportunities will be open to applications in the fall of 2015. All decisions regarding the review and selection of the submitted applications will be made by the AACR Scientific Review Committee in accordance with the policies and procedures of AACR.
Study highlights long-term risks of prostate cancer treatment